HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| ILMN | Illumina | NAM | 273.54 | -6.86% | +0.57% | +25.35% | +45.65% | +116.34% | +167.86% | USD |
| NTRA | Natera | NAM | 400.65 | -5.87% | -3.35% | +22.08% | +46.01% | +91.45% | +139.41% | USD |
| LLY | Eli Lilly | NAM | 1157.49 | +1.26% | -2.29% | +0.71% | -4.80% | +24.32% | +38.25% | USD |
| GXI.DE | Gerresheimer | EUR | 28.38 | -0.07% | +3.43% | -4.89% | -2.41% | +66.26% | -23.67% | EUR |
| AMGN | Amgen | NAM | 402.60 | -0.09% | -4.97% | -7.92% | +9.41% | +18.41% | +37.06% | USD |
| VRTX | Vertex Pharma | NAM | 502.31 | -0.24% | -4.64% | -8.02% | +0.78% | +16.31% | +24.55% | USD |
| REGN | Regeneron | NAM | 738.72 | +1.69% | -1.57% | -10.75% | +11.44% | -2.83% | +23.42% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 251.10 | -5.46% | -6.48% | -17.59% | -12.72% | -9.32% | -49.27% | DKK |
| VKTX | Viking Therapeutics | NAM | 28.38 | -3.07% | -10.78% | -18.61% | -28.98% | -15.79% | -4.51% | USD |
| NVO | Novo Nordisk | EUR | 37.53 | -2.66% | -2.04% | -19.46% | -23.24% | +1.68% | -34.75% | USD |